Compare Mueller Industries Inc. Common Stock (MLI) vs Oruka Therapeutics Inc. Common Stock (ORKA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Mueller Industries Inc. Common Stock vs Oruka Therapeutics Inc. Common Stock — how do they compare? Mueller Industries Inc. Common Stock trades at $60.63 (market cap $13.60B), while Oruka Therapeutics Inc. Common Stock trades at $75.2 (market cap $5.18B). The key difference: Mueller Industries Inc. Common Stock is far larger — about 2.6× Oruka Therapeutics Inc. Common Stock's market cap, and Mueller Industries Inc. Common Stock pays a 1.14% dividend while Oruka Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Mueller Industries Inc. Common Stock for 0 Days and Oruka Therapeutics Inc. Common Stock for 0 Days on average.
| MLI | ORKA | |
|---|---|---|
Market Cap | $13.60B | $5.18B |
Volume | 874,843 | 490,798 |
Sector | Industrials | Health |
52-Week High | $70.42 | $113.08 |
52-Week Low | $49.29 | $26.19 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $12.21B | $4.31B |
Dividend Yield | 1.14% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Mueller Industries Inc. Common Stock
Mueller Industries, Inc. is a US industrial manufacturer and the only vertically integrated producer of copper tube, fittings, and brass rod and forgings in North America, operating through its Piping Systems, Industrial Metals, and Climate segments.
Read more on MLI →About Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →
